Literature DB >> 23265901

Synthesis and evaluation of 8-oxoadenine derivatives as potent Toll-like receptor 7 agonists with high water solubility.

Tomoaki Nakamura1, Hiroki Wada, Hirotaka Kurebayashi, Tom McInally, Roger Bonnert, Yoshiaki Isobe.   

Abstract

We report the discovery of novel series of highly potent TLR7 agonists based on 8-oxoadenines, 1 and 2 by introducing and optimizing various tertiary amines onto the N(9)-position of the adenine moiety. The introduction of the amino group resulted in not only improved water solubility but also enhanced TLR7 agonistic activity. In particular compound 20 (DSR-6434) indicated an optimal balance between the agonistic potency and high water solubility. It also demonstrated a strong antitumor effect in vivo by intravenous administration in a tumor bearing mice model.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23265901     DOI: 10.1016/j.bmcl.2012.11.114

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Structural requirements for TLR7-selective signaling by 9-(4-piperidinylalkyl)-8-oxoadenine derivatives.

Authors:  Hélène G Bazin; Yufeng Li; Juhienah K Khalaf; Sandra Mwakwari; Mark T Livesay; Jay T Evans; David A Johnson
Journal:  Bioorg Med Chem Lett       Date:  2015-01-31       Impact factor: 2.823

2.  Facile syntheses of functionalized toll-like receptor 7 agonists.

Authors:  Babatope Akinbobuyi; Matthew R Byrd; Charles A Chang; Mysa Nguyen; Zacharie J Seifert; Anne-Laure Flamar; Gerard Zurawski; Katherine C Upchurch; SangKon Oh; Stephen H Dempsey; Thomas J Enke; John Le; Hunter J Winstead; José R Boquín; Robert R Kane
Journal:  Tetrahedron Lett       Date:  2015-01-08       Impact factor: 2.415

3.  A novel systemically administered Toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models.

Authors:  Amy L Adlard; Simon J Dovedi; Brian A Telfer; Erina Koga-Yamakawa; Charlotte Pollard; Jamie Honeychurch; Timothy M Illidge; Masashi Murata; David T Robinson; Philip J Jewsbury; Robert W Wilkinson; Ian J Stratford
Journal:  Int J Cancer       Date:  2014-01-17       Impact factor: 7.396

4.  Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen.

Authors:  Alex C D Salyer; Giuseppe Caruso; Karishma K Khetani; Lauren M Fox; Subbalakshmi S Malladi; Sunil A David
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

5.  A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation.

Authors:  Jason D Marshall; Darren S Heeke; Eileen Rao; Sean K Maynard; David Hornigold; Christopher McCrae; Neil Fraser; Andrey Tovchigrechko; Li Yu; Nicola Williams; Sarah King; Martin E Cooper; Adeline M Hajjar; Jennifer C Woo
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

Review 6.  Anti-tumor Activity of Toll-Like Receptor 7 Agonists.

Authors:  Huju Chi; Chunman Li; Flora Sha Zhao; Li Zhang; Tzi Bun Ng; Guangyi Jin; Ou Sha
Journal:  Front Pharmacol       Date:  2017-05-31       Impact factor: 5.810

7.  Bioconjugation of Small Molecules to RNA Impedes Its Recognition by Toll-Like Receptor 7.

Authors:  Isabell Hellmuth; Isabel Freund; Janine Schlöder; Salifu Seidu-Larry; Kathrin Thüring; Kaouthar Slama; Jens Langhanki; Stefka Kaloyanova; Tatjana Eigenbrod; Matthias Krumb; Sandra Röhm; Kalina Peneva; Till Opatz; Helmut Jonuleit; Alexander H Dalpke; Mark Helm
Journal:  Front Immunol       Date:  2017-03-24       Impact factor: 7.561

8.  Synthetic Toll-like Receptors 7 and 8 Agonists: Structure-Activity Relationship in the Oxoadenine Series.

Authors:  Jay T Evans; Laura S Bess; Sandra C Mwakwari; Mark T Livesay; Yufeng Li; Van Cybulski; David A Johnson; Hélène G Bazin
Journal:  ACS Omega       Date:  2019-09-10

Review 9.  Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles.

Authors:  Deepender Kaushik; Arshpreet Kaur; Nikolai Petrovsky; Deepak B Salunke
Journal:  RSC Med Chem       Date:  2021-05-14

Review 10.  Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants.

Authors:  Sachin Bhagchandani; Jeremiah A Johnson; Darrell J Irvine
Journal:  Adv Drug Deliv Rev       Date:  2021-05-29       Impact factor: 15.470

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.